High Expression of DC-STAMP Gene Predicts Adverse Outcomes in AML
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.876689
Abstract: Acute myeloid leukemia (AML) is a genetically heterogeneous hematological malignancy with poor prognosis. We explored the RNA sequence data and clinical information of AML patients from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx)… read more here.
Keywords: stamp expression; high expression; expression; analysis ... See more keywords